REPUTABLE CLINICAL LABORATORY COMPANIES HAVE A NEW COMPETITOR in what has been called the Wild West of microbiome startups. Some of the companies in this nascent industry have been hailed for developing health breakthroughs while others have been indicted for fraud, according to Kaiser Health News. Either way, these companies are serving up a cautionary […]
Microbiome Startups Pushing into the Clinical Lab Space
Startup companies testing patients’ gut bacteria attracted approximately $1 billion in venture capital
- By Robert Michel
- > From the Volume XXIX, No. 2 - January 31, 2022 Issue
- Tags: Christopher Lynch, Clinical Laboratory, Clinical Pathologist, Crunchbase, Deepak Chopra, FBI, Federal Bureau of Investigation, George Church PhD, Harvard Medical School, Harvard T.H. Chan School of Public Health, human genome project, Kaiser Health News, KHN, King’s College London, lab intelligence, Massachusetts General Hospital, microbiologist, Microbiome, National Institutes of Health, NIH, Personal Genome Project, Pitchbook Data, Robert Winthrop, SEC, Securities and Exchange Commission, Stanford Medicine, uBiome, venture capital, Viome, Zoe
